Lancet Market Report 2025

The lancet market size has grown rapidly in recent years. It will grow from $2.52 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 11.2%. The growth during the historic period can be attributed to the increasing prevalence of diabetes, rising use of self-monitoring blood glucose, growing healthcare spending, expanding middle-class population, and the rising trend toward home diagnostics.

The lancet market size is expected to see rapid growth in the next few years. It will grow to $4.25 billion in 2029 at a compound annual growth rate (CAGR) of 11%. The growth in the forecast period can be attributed to the increasing diabetic population, rising prevalence of chronic diseases, expanding geriatric population, growing preference for home healthcare, and increasing incidence of infectious diseases. Major trends during the forecast period include advancements in lancet design, integration of smart features, technology-driven home diagnostics, developments in safety lancets, and progress in minimally invasive sampling.

The increasing prevalence of diabetes is expected to drive the growth of the lancet market in the coming years. Diabetes is a chronic condition that affects how the body converts food into energy due to issues with insulin production or utilization. This rise in diabetes cases is mainly attributed to unhealthy lifestyle habits such as poor diet, sedentary behavior, and growing obesity rates, which contribute to insulin resistance and elevated blood glucose levels. Lancets play a crucial role in diabetes management by allowing regular blood glucose monitoring through safe and accurate fingertip pricking. This monitoring is essential for effective disease control, early identification of glucose fluctuations, and timely adjustments in medication, diet, or lifestyle to avoid complications. For example, in November 2023, the American Diabetes Association, a US-based non-profit, reported that in 2022, about 25.5 million people in the United States were diagnosed with diabetes, representing 7.6% of the total population - a rise compared to previous years. Thus, the growing prevalence of diabetes is propelling the lancet market forward.

Leading companies in the lancet market are focusing on innovative technologies such as total path control vertical-drive technology to enhance sampling accuracy and reduce pain during blood collection. This technology ensures that the lancet needle moves in a straight, vertical path during insertion and withdrawal, minimizing lateral movement to reduce tissue damage, vibration, and discomfort. This results in a more precise and comfortable blood sampling experience. For instance, in July 2025, SteriLance Medical (Suzhou) Inc., a China-based medical device firm, launched the OneStep lancing device and SoftSense lancets in Spain. This cap-free, hidden-needle lancing solution utilizes patent-protected total path control vertical-drive technology to offer virtually painless blood sampling while improving user safety. The device features a simplified four-step workflow - insert, twist, press, and eject - that reduces preparatory actions by approximately 70% compared to traditional lancing pens.

In August 2024, MTD S.p.A., an Italy-based medical device company, acquired the Pen Needles and Blood Glucose Monitoring Systems (BGM) businesses of Ypsomed AG for an undisclosed sum. Through this acquisition, MTD S.p.A. aims to reinforce its global leadership in diabetes and obesity care by expanding its portfolio with advanced pen needles, lancets, and blood glucose monitoring systems. This move will boost production capacity and enable the company to enter high-growth markets like China and India while strengthening its footprint in North America and Europe. Ypsomed AG is a Switzerland-based manufacturer specializing in lancets and other self-injection devices.

Major players in the lancet market are Cardinal Health Inc., F. Hoffmann-La Roche Ltd, Abbott Laboratories, Becton Dickinson and Company, Terumo Corporation, SARSTEDT AG & Co. KG, B. Braun Melsungen AG, Owen Mumford Limited, Amkay Products Pvt. Ltd, Quest Medical Inc., NARANG MEDICAL LIMITED, GBUK GROUP LIMITED, ARKRAY HEALTHCARE PRIVATE LIMITED, Sterimed Medical Devices Private Limited, MediPoint Holdings, MediPurpose Pte. Ltd, Carelife USA Inc., Germaine Laboratories Inc., Shandong Lianfa Medical Plastic Products Co. Ltd, and Ambimed Healthcare Private Limited.

North America was the largest region in the lancet market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in lancet report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the lancet market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The lancet market consists of sales of adjustable-depth lancets, pediatric lancets, blood glucose testing kits, multi-lancet devices, and heel lancets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The lancet market research report is one of a series of new reports that provides lancet market statistics, including the lancet industry global market size, regional shares, competitors with the lancet market share, detailed lancet market segments, market trends, and opportunities, and any further data you may need to thrive in the lancet industry. This lancet market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

A lancet is a small, sharp, double-edged surgical instrument typically utilized for making quick, precise incisions or punctures in the skin, most commonly employed in procedures such as blood sampling, abscess drainage, or minor surgeries. It is an essential tool in both clinical and laboratory settings because of its ease of use, sterilizability, and effectiveness in minimizing tissue damage.

The main types of lancets comprise safety lancets, push button safety lancets, pressure-activated safety lancets, side button safety lancets, and personal lancets. A safety lancet is a single-use device featuring an automatic needle retraction mechanism designed to ensure safe, hygienic, and low-pain blood sampling while reducing the risk of needlestick injuries and cross-contamination. These lancets come in various gauge sizes, including 22 gauge and below, 23 to 33 gauge, and above 33 gauge. They are utilized in applications such as glucose testing, hemoglobin testing, coagulation testing, cholesterol testing, allergy testing, neonatal testing, and others. The primary end users of these lancets include hospitals, clinics, ambulatory surgery centers, homecare settings, and more.

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.